2C or not 2C: phenethylamine designer drug review
- PMID: 23494844
- PMCID: PMC3657019
- DOI: 10.1007/s13181-013-0295-x
2C or not 2C: phenethylamine designer drug review
Abstract
New groups of synthetic "designer drugs" have increased in popularity over the past several years. These products mimic the euphoric effects of other well-known illicit drugs but are advertised as "legal" highs and are sold over the internet, at raves and night clubs, and in head shops. The 2C series drugs are ring-substituted phenethylamines that belong to a group of designer agents similar in structure to 3,4-methylenedioxy-N-methylamphetamine (MDMA, Ecstasy). Understanding the pharmacology and toxicology of these agents is essential in order to provide the best medical care for these patients. This review focuses on the pharmacology, pharmacokinetics, clinical effects, and treatment of 2C drug intoxication based on available published literature. Multiple names under which 2C drugs are sold were identified and tabulated. Common features identified in patients intoxicated with 2Cs included hallucinations, agitation, aggression, violence, dysphoria, hypertension, tachycardia, seizures, and hyperthermia. Patients may exhibit sympathomimetic symptoms or symptoms consistent with serotonin toxicity, but an excited delirium presentation seems to be consistent amongst deaths attributed to 2C drugs; at least five deaths have been reported in the literature in patients intoxicated with 2C drugs. 2C drugs are a group of designer intoxicants, many of which are marketed as legal, but may carry risks that consumers are unaware of. These drugs may be characterized by either serotonergic toxicity or a sympathomimetic toxidrome, but a presentation consistent with excited delirium is consistent amongst the reported 2C-related deaths. Treatment of 2C intoxication is primarily supportive, but immediate action is required in the context of excited delirium, hyperthermia, and seizure activity.
Figures
Similar articles
-
Clinical toxicology of newer recreational drugs.Clin Toxicol (Phila). 2011 Oct;49(8):705-19. doi: 10.3109/15563650.2011.615318. Clin Toxicol (Phila). 2011. PMID: 21970769 Review.
-
Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling.Swiss Med Wkly. 2015 Jan 14;145:w14043. doi: 10.4414/smw.2015.14043. eCollection 2015. Swiss Med Wkly. 2015. PMID: 25588018 Review.
-
2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe): clinical case with unique confirmatory testing.J Med Toxicol. 2014 Mar;10(1):45-50. doi: 10.1007/s13181-013-0314-y. J Med Toxicol. 2014. PMID: 23872917 Free PMC article.
-
Interactions of phenethylamine-derived psychoactive substances of the 2C-series with human monoamine oxidases.Drug Test Anal. 2019 Feb;11(2):318-324. doi: 10.1002/dta.2494. Epub 2018 Sep 28. Drug Test Anal. 2019. PMID: 30188017
-
Gas Chromatography Mass Spectrometry (GC-MS) for Identification of Designer Stimulants Including 2C Amines, NBOMe Compounds, and Cathinones in Urine.Curr Protoc Toxicol. 2017 Nov 8;74:4.43.1-4.43.10. doi: 10.1002/cptx.33. Curr Protoc Toxicol. 2017. PMID: 29117432
Cited by
-
Potential Functional Role of Phenethylamine Derivatives in Inhibiting Dopamine Reuptake: Structure-Activity Relationship.Biomol Ther (Seoul). 2023 Jan 1;31(1):108-115. doi: 10.4062/biomolther.2022.047. Epub 2022 Sep 13. Biomol Ther (Seoul). 2023. PMID: 36098044 Free PMC article.
-
Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities.Front Immunol. 2015 Jul 14;6:358. doi: 10.3389/fimmu.2015.00358. eCollection 2015. Front Immunol. 2015. PMID: 26236313 Free PMC article. Review.
-
Electrical weapons and excited delirium: shocks, stress, and serum serotonin.Forensic Sci Med Pathol. 2018 Dec;14(4):478-483. doi: 10.1007/s12024-018-0005-8. Epub 2018 Aug 11. Forensic Sci Med Pathol. 2018. PMID: 30099702
-
Stereoselective inhibition of serotonin transporters by antimalarial compounds.Neurochem Int. 2014 Jul;73:98-106. doi: 10.1016/j.neuint.2013.10.009. Epub 2013 Oct 23. Neurochem Int. 2014. PMID: 24161619 Free PMC article.
-
Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants.Front Neurosci. 2016 Apr 19;10:153. doi: 10.3389/fnins.2016.00153. eCollection 2016. Front Neurosci. 2016. PMID: 27147945 Free PMC article. Review.
References
-
- Drug Enforcement Administration [webpage on the Internet]. Drugs of abuse, 2011 edition. Washington, DC: Drug Enforcement Administration [updated 2012 Jun 20]. Available from: http://www.justice.gov/dea/docs/drugs_of_abuse_2011.pdf. Accessed 12 Feb 2013
-
- Shulgin AT, Shulgin A. PIHKAL: a chemical love story. Berkeley: Transform Press; 1991.
-
- Erowid[webpage on the Internet]. Erowid 2C-B Vault Basics. Grass Valley, CA; Erowid [updated 2011 Feb 11]. Available from: http://www.erowid.org/chemicals/2cb/2cb_basics.shtml. Accessed 12 Feb 2013
-
- Wikipedia [webpage on the Internet]. 2C (psychedelics). San Francisco, CA; Wikipedia Foundation, Inc. [updated 2012 Nov 27]. Available from: http://en.wikipedia.org/wiki/2C_%28psychedelics%29. Accessed 12 Feb 2013
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous